Patents by Inventor Bridget Ferns

Bridget Ferns has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 7393933
    Abstract: A monoclonal antibody that is capable of binding specifically to wild type HBsAg and to at least two mutant forms of HBsAg may be used in an improved immunoassay for the detection of both escape mutants and wild type HBsAg and may be used for passive immunisation against HBV.
    Type: Grant
    Filed: April 25, 1997
    Date of Patent: July 1, 2008
    Inventors: Richard Seton Tedder, Samreen Ijaz, Ruth Bridget Ferns
  • Patent number: 4912030
    Abstract: Samples e.g. transfusion blood, are assayed for antibodies to retroviruses, e.g. AIDS virus, using an insolubilized antigen comprising retrovirus antigens bound to globulin, the globulin itself being bound to an inert solid support; and an immunoglobulin which contains specific antibody to the retrovirus antigens and which is labelled with a revealing label, and the soluble phase is then separated from the insoluble phase and the quantity of revealing label associated with either the soluble or the insoluble phase determined.The sue of labelled antibody in competition with test sera for binding on the insolublized antigen permits better identification of antibody containing specimens. The retroviruses may be a human T-lymphotropic retrovirus HTLV-I, II or III or a new retrovirus isolate CBL-1 etiologically related to AIDS.
    Type: Grant
    Filed: April 5, 1988
    Date of Patent: March 27, 1990
    Assignee: Institute of Cancer Research
    Inventors: Robin Weiss, Richard Tedder, Rachanee Cheingsong-Popov, Bridget Ferns